Radiopharm Doses First Patient in Phase I Prostate Cancer Radiotherapy Study
Alpha‑Emitting PSMA Therapies Gain Momentum Across Radiopharma Leaders
Ratio Therapeutics Highlights the Next Wave of Radiopharmaceutical Manufacturing Standards
Radiopharma Veterans From Novartis‑Built Platforms Strengthen Emerging Biotechs
Radiopharma Takes Center Stage as Global Biopharma Partnering Accelerates

Modulating Tumor Microenvironment– Mediated Resistance Mechanisms to Enhance Therapeutic Response in Preclinical Models

By | 6 March 2026

Immune modulation of the TME as a strategy to enhance anti-tumor immunity
Combinatorial therapeutic strategies to leverage TME modulation with anti-tumor immunotherapies
Targeting the TME with preclinical interventions